LakeShore Biopharma Co (LakeShore Biopharma Co) FCF Yield % : -23.38 (As of Jun. 03, 2024)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, LakeShore Biopharma Co's Trailing 12-Month Free Cash Flow is $-39.63 Mil, and Market Cap is $169.50 Mil. Therefore, LakeShore Biopharma Co's FCF Yield % for today is -23.38%.

The historical rank and industry rank for LakeShore Biopharma Co's FCF Yield % or its related term are showing as below:

LSB' s FCF Yield % Range Over the Past 10 Years
Min: -100.95 Med: -44.08 Max: -7.97
Current: -23.38

During the past 3 years, the highest FCF Yield % of LakeShore Biopharma Co was -7.97%. The lowest was -100.95%. And the median was -44.08%.

LSB's FCF Yield % is ranked worse than
63.27% of 1552 companies
in the Biotechnology industry
Industry Median: -14.1 vs LSB: -23.38

LakeShore Biopharma Co's FCF Margin % for the quarter that ended in Sep. 2023 was -62.03%.

LakeShore Biopharma Co FCF Yield % Historical Data

The historical data trend for LakeShore Biopharma Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co FCF Yield % Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

FCF Yield %

-23.34

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	-22.05	-62.36

Competitive Comparison of LakeShore Biopharma Co's FCF Yield %

For the Biotechnology subindustry, LakeShore Biopharma Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's FCF Yield % falls into.

LakeShore Biopharma Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

LakeShore Biopharma Co's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-34.759	/	148.89312
	=	-23.34%

LakeShore Biopharma Co's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-23.214	*	2	/	74.44656
	=	-62.36%

LakeShore Biopharma Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

LakeShore Biopharma Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.